Tranexamic acid inhibits melanogenesis partially via stimulation of TGF‐β1 expression in human epidermal keratinocytes
Tranexamic acid inhibits melanogenesis partially via stimulation of TGF‐β1 expression in human epidermal keratinocytes
复制标题
DOI:
10.1111/exd.14509
复制
发表时间:
2021-12
影响因子:
3.6
通讯作者:
X. Xing;Zhongyi Xu;Li Chen;Shanglin Jin;Chengfeng Zhang;L. Xiang
中科院分区:
文献类型:
--
作者:
X. Xing;Zhongyi Xu;Li Chen;Shanglin Jin;Chengfeng Zhang;L. Xiang
Oral tranexamic acid (TA) has been an effective treatment for melasma with unclear mechanism. The present study aimed to demonstrate the effect of TA on melanogenesis via regulation of TGF‐β1 expression in keratinocytes. We firstly determined the expression level of TGF‐β1 in TA‐treated keratinocyte‐conditioned medium (KCM). Then, the mRNA and protein levels of microphthalmia‐associated transcription factor (MITF), tyrosinase (TYR) and tyrosinase‐related protein 1 (TRP‐1) of human epidermal melanocytes (NHEMs) in the presence of TA‐treated KCM were evaluated via RT‐PCR and western blot analysis. Moreover, melanin content and tyrosinase activity were quantified. TGF‐β1 gene was knocked down by small interfering RNA (siRNA) in keratinocytes. The mRNA and protein levels of TGF‐β1 in keratinocytes were significantly increased after TA treatment. Melanin contents, tyrosinase activity, protein and mRNA levels of TYR, MITF and TRP‐1 were downregulated in NHEMs in the presence of TA‐treated KCM. Knockdown of TGF‐β1 in keratinocytes could attenuate the inhibitory effect of TA‐treated KCM on melanogenesis. TA could stimulate TGF‐β1 expression in keratinocytes, which further inhibits melanogenesis through the paracrine signalling.